Patent details

91089 Product Name: IBRITUMOMAB

Basic Information

Publication number:
91089
Type:
SPC
SPC Type:
Medical
Basic Patent Number:
EP949014443
Legal Status:
Expired
Application number:
91089
First applicant's nationality:
Procedural language:
French

Marketing Authorization

Marketing Authorization Number:
eu/1/03/264/001
Marketing Authorization Type:
Marketing Authorization Date:
16/01/2004
Marketing Authorization Status:
Accepted
Marketing Authorization Country:

Dates

Filing date:
16/07/2004
First Marketing Authorization date:
16/01/2004
Grant date:
16/09/2004
Activation date:
12/11/2013
Publication date:
16/09/2004
Lapsed date:
Expiration date:
Renunciation date:
Revocation date:
Annulment date:
Basic SPC Expiration:
12/11/2018
SPC Extension Expiration:
12/11/2018
Rejection date:
Withdrawal date:

Owner

From:
11/06/2015
 
 

Name:
BIOGEN INC.
Address:
225 BINNEY STREET, CAMBRIDGE, MA 02142, United States (US)

History of Owners

From:
16/07/2004
To:
10/06/2015

Name:
BIOGEN IDEC INC.
Address:
RESEARCH PLACE 5200, SAN DIEGO, CA 92122, United States (US)

Agent

Name:
OFFICE FREYLINGER S.A.
From:
16/07/2004
Address:
PO Box 48, 8001, STRASSEN, Luxembourg (LU)
To:

Inventor

1

Name:
ANDERSON Darrell, R.
Address:
United States (US)

2

Name:
REFF Mitchell, E.
Address:
United States (US)

3

Name:
LEONARD John, E.
Address:
United States (US)

4

Name:
NEWMAN Roland, A.
Address:
United States (US)

5

Name:
HANNA Nabil
Address:
United States (US)

6

Name:
RASTETTER William, H.
Address:
United States (US)

Annual Fees

Annual Fee Due Date:
Annual Fee Number:
Expected Payer:
Last Annual Fee Payment Date:
29/05/2018
Last Annual Fee Paid Number:
25
Last Annual Fee Paid Amount:
450 Euro
Payer:
ENVOY INTERNATIONAL LIMITED
Filing date Document type Number of pages